Issue Date: January 2023
As previously reported, the 2023 Consolidated Appropriations Act (CAA 2023) includes language extending the temporary relief permitting telemedicine plans to be offere...
On the eve of the requirement for employer-sponsored health plans and health insurance carriers to submit prescription drug cost reporting data (RxDC), the Departments of Labor, Health and Human Servi...
Employers may choose self-funded group health plan coverage to obtain more flexibility with plan design and hopefully save some money. However, in doing so, there are additional responsibilities and c...
The RxDC reporting provision of the Consolidated Appropriations Act (CAA) requires reports on drug utilization and spending trends to be submitted to U.S. Department of Health and Human Services begin...
At the time we originally distributed the announcement for the IRS and ACA limits for 2023, the new PCORI Fee amount was projected to be $2.93 for Plan Years ending on or after October 1, 2022 and bef...
Recent federal policy changes will impact compliance for Self-Funded Plans, Group Health Plans, and all Applicable Large Employers (ALEs).
ALEs are those employers offering group health plans that ...
Starting January 1, 2023, a new law will require most types of insurance producers, as well as independent insurance adjusters, public insurance adjusters, and analysts, to include their license numbe...
The IRS has issued final regulations that change the way employer-sponsored plan affordability is calculated when determining if a family is eligible for a premium tax credit (PTC) when purchasing ind...
With many group health plan renewals approaching, brokers or consultants will need to remember to provide the compensation disclosure passed into law with the Consolidated Appropriations Act, 2021 (CA...
Background & Purpose
Employers sponsoring a fully-insured group health plan may soon be getting a check from their insurer. This check is a medical loss ratio (MLR) rebate that insurers are requi...
Question: I’ve heard that the prescription drug reporting requirement under the transparency rules was delayed. Does this mean I don’t need to worry about any impending requirements?
Answer:
T...